MedTrace Logo

A Eye Movement Desensitization Reprocessing (EMDR) Study in Bipolar Traumatized Patients

NCT01620866 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-06-19

No results posted yet for this study

Summary

The purpose of this pilot study is whether Eye Movement Desensitization Reprocessing (EMDR), an approved psychotherapy in posttraumatic stress disorder, improves mood, functioning, quality of life, cognition and BDNF levels in subsyndromal bipolar patients with trauma.

Conditions

Interventions

OTHER

Eye Movement Desensitization Reprocessing (EMDR)

EMDR is an effective treatment in PTSD but has never been tested in bipolar traumatized patients.

Sponsors & Collaborators

  • FIDMAG Germanes Hospitalàries

    lead OTHER

Principal Investigators

  • Benedikt L Amann, MD · FIDMAG Germanes Hospitalàries

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01620866 on ClinicalTrials.gov